Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Processing

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

By Dan Stanton , 20-Feb-2013
Last updated the 20-Feb-2013 at 11:11 GMT

ATMI single-use bioprocessing system
ATMI single-use bioprocessing system
Loading...

New innovations in single-use bioprocessing systems are being picked up quicker in Europe than in the US, according to ATMI.

in-Pharmatechnologist.com was at ATMI’s facility in Hoegaarden, Belgium to meet Global Product Manager, Eric Isberg and discuss market demand and future innovations in bioreactors and mixing systems.

“If anything, Europe is ahead of the US in terms of innovation and single-use” he said, adding that “maybe if Asia takes on some of this innovation it will push [America] further to become innovative.”

The point was illustrated with ATMI’s Integrity Padreactor, a single-use bioreactor for growing cell cultures, which is cubed rather than cylindrical.

According to Isberg, this ‘square’ reactor can offer better mixing results than traditional ‘round’ tanks yet has not readily been taken up by the US market due to preconceptions based on multi-use stainless-steel systems.

“The square tank was very difficult to clean in the stainless versions,” he said. “Most engineers immediately resist [the square system] because of the cleanability, but of course with single-use you don’t have cleanability issues.”

Global demand for single-use bioreactors is also increasing according to ATMI global sales director Roel Gordijn who told us that although traditional markets still dominate “economies like India, China, Brazil are really picking up now.”

There was some optimism throughout the facility tour and a real belief that single-use bioprocessing solutions would become the standard for the industry. This echoes previous comments that ATMI has said to this publication as ATMI continue to widen its capabilities and offer new innovations to fully integrate the unconventional systems in the biotech world.

Related products

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Will Downie

Senior VP Global Vusiness Development & Marketing, Catalent

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Quincy Mattingly

Regional Manager, AlpVision

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

ASI has teamed up with Chromatan in order to deliver single-use and column-free capture...

Updated IPEC Guide Steers Excipient Manufacturers Away From Unnecessary Tests

John Giannone - incoming IPEC-Americas chairman

Irwin Silverstein, COO and VP of the International Pharmaceutical Excipients...

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

Special Report from ATMI's Belgian Facility

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

Walter Dissinger

President , BASF nutrition and health

Optimism is returning to the pharma fine chemicals sector, says analyst

Optimism is returning to the pharma fine chemicals sector, says analyst

Jan Ramakers

Industry consultant, Jan Ramakers Fine Chemical Consulting Group

Capsugel expands liquid fill capsule capabilities

Keith Hutchison,

Senior VP of research and development (R&D) , Capsugel

New filtration tech boosts biomanufacturing yields, says Sartorius

New filtration tech boosts biomanufacturing yields, says Sartorius

Jens Meyer

Product manager for filtration technologies, Sartorius Stedim

Submit good REMS proposals for FDA brownie points, says RAPS author

Submit good REMS proposals for FDA brownie points, says RAPS author

Ed Tabor

VP of strategic drug development , Quintiles

Capsugel: Micro-Dosing Tech Can Cut Drug Development by 6 Months

Capsugel: Micro-Dosing Tech Can Cut Drug Development by 6 Months

Missy Lowery

Marketing Manager for the Americas, Capsugel

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Cory Stevenson & Brandon Pence

Thermo Fisher Scientific

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

Eric Isberg

Global Product Manager, ATMI

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Purification bottlenecks, integrating single-use technologies and low cost companies are just some of the...

Happy holidays from William Reed Business Media!

Happy holidays from William Reed Business Media!

The working year is almost done, time to pause from ‘the business’ and embrace...

Key Industry Events

 

Access all events listing

Our events, Events from partners...